Beta Bionics, Inc. (BBNX) is a leading medical device innovator focused on transforming the management of diabetes through the design and commercialization of advanced insulin delivery systems. Headquartered in Irvine, California, the company is committed to improving the health and quality of life for individuals reliant on insulin by leveraging cutting-edge technology and patient-centric solutions. With a strong emphasis on research and development, Beta Bionics aims to address the unmet needs of the diabetes community, positioning itself as a pioneer in the evolving healthcare landscape.